Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
about
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney CancerHuman genetics and genomics a decade after the release of the draft sequence of the human genomeCancer genome landscapesEpigenetic modifications in cancerASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repressionA tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functionsSinefungin derivatives as inhibitors and structure probes of protein lysine methyltransferase SETD2Histone methyltransferase SETD2 coordinates FACT recruitment with nucleosome dynamics during transcriptionThe tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal functionExome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaThe histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSαNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesMetabolism of kidney cancer: from the lab to clinical practiceCovalent histone modifications--miswritten, misinterpreted and mis-erased in human cancersInternational network of cancer genome projects.Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genesThe histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetFrequent mutation of histone-modifying genes in non-Hodgkin lymphomaState of the science: an update on renal cell carcinomaMassive genomic rearrangement acquired in a single catastrophic event during cancer developmentThe Impact of External Factors on the Epigenome: In Utero and over LifetimeEpigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathologyEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionTargeting EZH2 in cancerSerine, glycine and one-carbon units: cancer metabolism in full circleDecade in review-kidney cancer: discoveries, therapies and opportunitiesNew developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in gliomaRecent progress toward epigenetic therapies: the example of mixed lineage leukemiaEpigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumorsKidney cancerHistone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionMyeloid malignancies: mutations, models and managementNew insights and challenges in mismatch repair: getting over the chromatin hurdleEmerging patterns of somatic mutations in cancerEvolution of the cancer genomeHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaCancer immunotherapyInhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential.The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
P2860
Q21090542-28E16B00-00EB-4266-B259-DCE0AC97CF79Q21245451-4B8B42B0-47BF-4F17-B45D-68BD47B8BF50Q22242276-F5E59417-81B6-4573-96A0-FA683CF38642Q22242610-75DAA5EE-9B40-4FA3-9974-7B0C2F077D08Q24296658-FF4F9680-09F4-490D-8B88-D3F33D3D3850Q24299493-FC74097D-B696-47CD-BD7E-666900AAC233Q24300459-B43B0531-B79E-4896-AB67-12E8F7A47978Q24309566-979C18A4-65F6-459E-B6BD-C4ECA2191040Q24312781-7F6AC078-4976-4513-993A-4094577C8E7FQ24337664-B0662B9E-CC51-418F-8310-71A27771AAD9Q24339204-FDB97FA0-D741-4F82-95A2-351729151E92Q24596715-30ED9C81-D93A-48E7-8B98-1F9697CF3D40Q24600512-C23E2E92-2CDC-44AB-A9D2-A552F2FEE507Q24605342-699A1157-AEA5-4138-B422-9EA2220223CCQ24611474-479C65CF-4C92-4D52-9B0C-26ECA0CB2240Q24619351-170C537B-2026-4AAE-AAAA-1E57F28862C8Q24625220-59977622-99AE-4E62-BE2B-D1A3FBEBB042Q24630610-F49AFC5F-BAD2-4906-AE86-F553FAF27C36Q24630685-EF108E27-2FAD-4198-AC6F-BEDF8020DD23Q24631164-7BF13C4E-4FFA-4946-863D-96FA779F30EEQ26746703-8B6034D9-4257-4689-B689-20F819C2E969Q26752925-ADC11338-CDD5-46B6-BFE3-EC16D4BF0AC6Q26766149-2022CA21-0E76-41BA-A14D-4BE57B1AF2E3Q26769027-BEFBB53D-CEDC-4143-B2CD-8A3D1E3CB071Q26828610-02569EBC-2820-49A2-A908-F4525F88A068Q26853533-C522026C-73E2-4384-956D-6C6784E57094Q26863394-C0DBBDB9-A5D3-49C0-8AC3-A8537A8BE8A0Q26863577-5463B7AD-633E-4473-B831-A5D36AAD05ECQ26864920-B3236C9E-AB51-466B-A559-312C884519D1Q26866709-6FB154F3-FF2D-4C91-92C3-033FA4E73B35Q26994739-388AAF8E-6478-4A67-A224-37CEF6B1552CQ27000577-12B70F29-C905-45FD-8448-6A64854FFF9AQ27011117-E79F080B-8029-4E75-B30C-A8E314D9BF6EQ27014126-FD3D3EFB-F7E0-44E9-8A7B-FE1654D048A7Q27020991-6A49C159-334C-44FA-A4C0-11EED0A788C8Q27025886-749D04DE-871F-406D-84D1-164839466D02Q27025984-45A5302E-DA82-4029-997C-87B44E1E403FQ27026870-9E7D273D-F93A-4F4C-9F31-96BFD13C8993Q27304863-4E870D3E-E94C-4412-8F1B-9371DFB52BB9Q27667409-50E6BD3C-3A4F-4FF1-A585-2061DEA443A1
P2860
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@ast
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@en
type
label
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@ast
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@en
prefLabel
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@ast
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
@en
P2093
Adam Butler
Arjunan Rajasingham
Bill Wondergem
Catherine Leroy
Chai Yin Kok
Chris Greenman
Claire Hardy
Dave Beare
David J McBride
David Jones
P2860
P2888
P304
P3181
P356
10.1038/NATURE08672
P407
P50
P577
2010-01-06T00:00:00Z
P5875
P6179
1032969139